Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Arcutis Biotherapeutics stock have a consensus rating of "Strong Buy" and an average price target of $19, which forecasts a 6.50% increase in the stock price over the next year. The lowest target is $15 and the highest is $22.

Price Target: $19 (+6.50%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$19	$19	$22
Change	-15.92%	+6.50%	+6.50%	+23.32%

* Price targets were last updated on Aug 7, 2025.

Analyst Ratings

The average analyst rating for Arcutis Biotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	4	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Maintains $20 → $22	Strong Buy	Maintains	$20 → $22	+23.32%	Aug 7, 2025
Richard Law Goldman Sachs	Goldman Sachs	Hold Initiates $18	Hold	Initiates	$18	+0.90%	Jul 25, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+12.11%	May 23, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+12.11%	Apr 9, 2025
Seamus Fernandez Guggenheim	Guggenheim	Strong Buy Reiterates n/a	Strong Buy	Reiterates	n/a	n/a	Apr 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

338.95M

Increased by 72.46%

from 196.54M

Revenue Next Year

446.38M

Increased by 31.69%

from 338.95M

EPS This Year

-0.47

from -1.16

EPS Next Year

0.13

from -0.47

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	3.69M	59.61M	196.54M	338.95M	446.38M
Revenue Growth	-	-	-	1,517.09%	229.74%	72.46%	31.69%
EPS	-3.80	-4.18	-5.66	-3.78	-1.16	-0.47	0.13
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	139.77
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	364.4M	491.8M
Avg	339.0M	446.4M
Low	316.7M	410.5M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	85.4%	45.1%
Avg	72.5%	31.7%
Low	61.1%	21.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.37	0.42
Avg	-0.47	0.13
Low	-0.51	-0.21

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.